Attempting to learn and process large amounts of complex information after a diagnosis of pancreatic cancer can leave anyone feeling lost. So where should you turn? Start with Patient Central.
Receiving a pancreatic cancer diagnosis can stop a family in their tracks. Not only must patients and their loved ones navigate the emotional impact, but they are often asked to make quick treatment decisions. Attempting to learn and process large amounts of complex information can leave anyone feeling lost.
So where should you turn? Start with Patient Central.
The Pancreatic Cancer Action Network’s Patient Central is the first place to call after a diagnosis of pancreatic cancer or at any point in your journey. Patient Central Associates can help provide information for any question you have about pancreatic cancer. An Associate can also help you navigate the most critical decisions you’ll need to make to:
Contact Patient Central for personalized, one-to-one support from an Associate. All information and services are provided free of charge because of the philanthropy of generous friends.
This article was originally published by the Pancreatic Cancer Action Network. It is republished with permission.
GVAX Cancer Vaccine Generates Responses in Patients With Pancreatic Adenocarcinoma
August 16th 2023The median disease-free survival with GVAX vaccine plus low-dose cyclophosphamide; GVAX plus cyclophosphamide and nivolumab; and GVAX plus cyclophosphamide, nivolumab, and urelumab, was 13.90 months, 26.1 months, and 31.6 months, respectively.
Neoadjuvant Durvalumab Combination Misses Mark in EGFR+ NSCLC
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
2 Clarke Drive
Cranbury, NJ 08512